DART DUAL ACTION REGENERATION TECHNOLOGY Trademark

Trademark Overview

On Friday, July 17, 2026, a trademark application was filed for DART DUAL ACTION REGENERATION TECHNOLOGY with the United States Patent and Trademark Office. The USPTO has given the DART DUAL ACTION REGENERATION TECHNOLOGY trademark a serial number of 99946242. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, July 17, 2026. This trademark is owned by Allergan Pharmaceuticals International Limited. The DART DUAL ACTION REGENERATION TECHNOLOGY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Scientific research in the fields of biotechnology, pharmaceutical and aesthetic product development; none of the aforesaid services relating to the fields of biostasis, cryonics, cryogenic preservation, vitrification, cryotransport, cryopreservation or chemopreseveration

Pharmaceutical preparations to treat dermatological conditions; medicinal preparations for the treatment of dermatological conditions; injectable dermal fillers; pharmaceutical preparations for skin care; medical preparations consisting of a dermatological preparation, namely, syringes sold filled with medicated dermatological preparations for filling lines, wrinkles and lips, for tightening the face and body and for rejuvenating the skin; injectable dermatological pharmaceutical products to treat dermatological conditions
dart dual action regeneration technology

General Information

Serial Number99946242
Word MarkDART DUAL ACTION REGENERATION TECHNOLOGY
Filing DateFriday, July 17, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, July 17, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesScientific research in the fields of biotechnology, pharmaceutical and aesthetic product development; none of the aforesaid services relating to the fields of biostasis, cryonics, cryogenic preservation, vitrification, cryotransport, cryopreservation or chemopreseveration
Goods and ServicesPharmaceutical preparations to treat dermatological conditions; medicinal preparations for the treatment of dermatological conditions; injectable dermal fillers; pharmaceutical preparations for skin care; medical preparations consisting of a dermatological preparation, namely, syringes sold filled with medicated dermatological preparations for filling lines, wrinkles and lips, for tightening the face and body and for rejuvenating the skin; injectable dermatological pharmaceutical products to treat dermatological conditions
Pseudo MarkDUAL ACTION REGENERATION TECHNOLOGY DUAL ACTION REGENERATION TECHNOLOGY

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 17, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 17, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAllergan Pharmaceuticals International Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDublin 17 D17 E400
IE

Trademark Events

Event DateEvent Description
Friday, July 17, 2026NEW APPLICATION ENTERED
Friday, July 17, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

technology regeneration action dual dart dermatological preparations pharmaceutical conditions treat fields skin injectable preparation syringes